136 related articles for article (PubMed ID: 37622164)
1. Preliminary Assessment of Reference Region Quantification and Reduced Scanning Times for [
Smart K; Uribe C; Desmond KL; Martin SL; Vasdev N; Strafella AP
Mol Imaging; 2023; 2023():1855985. PubMed ID: 37622164
[TBL] [Abstract][Full Text] [Related]
2. First-in-Human Evaluation of
Naganawa M; Li S; Nabulsi N; Henry S; Zheng MQ; Pracitto R; Cai Z; Gao H; Kapinos M; Labaree D; Matuskey D; Huang Y; Carson RE
J Nucl Med; 2021 Apr; 62(4):561-567. PubMed ID: 32859701
[TBL] [Abstract][Full Text] [Related]
3. Quantification of SV2A Binding in Rodent Brain Using [
Sadasivam P; Fang XT; Toyonaga T; Lee S; Xu Y; Zheng MQ; Spurrier J; Huang Y; Strittmatter SM; Carson RE; Cai Z
Mol Imaging Biol; 2021 Jun; 23(3):372-381. PubMed ID: 33258040
[TBL] [Abstract][Full Text] [Related]
4. Assessment of test-retest reproducibility of [
Li S; Naganawa M; Pracitto R; Najafzadeh S; Holden D; Henry S; Matuskey D; Emery PR; Cai Z; Ropchan J; Nabulsi N; Carson RE; Huang Y
Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1327-1338. PubMed ID: 33416954
[TBL] [Abstract][Full Text] [Related]
5. Preclinical Evaluation and Quantification of
Khanapur S; van Waarde A; Dierckx RA; Elsinga PH; Koole MJ
J Nucl Med; 2017 Mar; 58(3):466-472. PubMed ID: 27789720
[TBL] [Abstract][Full Text] [Related]
6. Synaptic density in aging mice measured by [
Xiong M; Roshanbin S; Sehlin D; Hansen HD; Knudsen GM; Rokka J; Eriksson J; Syvänen S
Neuroimage; 2023 Aug; 277():120230. PubMed ID: 37355199
[TBL] [Abstract][Full Text] [Related]
7. Quantification and discriminative power of
Delva A; Van Weehaeghe D; van Aalst J; Ceccarini J; Koole M; Baete K; Nuyts J; Vandenberghe W; Van Laere K
Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1913-1926. PubMed ID: 31776633
[TBL] [Abstract][Full Text] [Related]
8. Parametric imaging and quantitative analysis of the PET amyloid ligand [(18)F]flutemetamol.
Heurling K; Buckley C; Van Laere K; Vandenberghe R; Lubberink M
Neuroimage; 2015 Nov; 121():184-92. PubMed ID: 26209803
[TBL] [Abstract][Full Text] [Related]
9. First-in-Human Study of
Drake LR; Wu Y; Naganawa M; Asch R; Zheng C; Najafzadeh S; Pracitto R; Lindemann M; Li S; Ropchan J; Labaree D; Emery PR; Dias M; Henry S; Nabulsi N; Matuskey D; Hillmer AT; Gallezot JD; Carson RE; Cai Z; Huang Y
J Nucl Med; 2024 Feb; 65(3):462-9. PubMed ID: 38360052
[TBL] [Abstract][Full Text] [Related]
10. Validation of Parametric Methods for [
Mertens N; Maguire RP; Serdons K; Lacroix B; Mercier J; Sciberras D; Van Laere K; Koole M
Mol Imaging Biol; 2020 Apr; 22(2):444-452. PubMed ID: 31209780
[TBL] [Abstract][Full Text] [Related]
11. Validation of Noninvasive Tracer Kinetic Analysis of
Bullich S; Barthel H; Koglin N; Becker GA; De Santi S; Jovalekic A; Stephens AW; Sabri O
J Nucl Med; 2018 Jul; 59(7):1104-1110. PubMed ID: 29175981
[TBL] [Abstract][Full Text] [Related]
12. A metabolically stable PET tracer for imaging synaptic vesicle protein 2A: synthesis and preclinical characterization of [
Zheng C; Holden D; Zheng MQ; Pracitto R; Wilcox KC; Lindemann M; Felchner Z; Zhang L; Tong J; Fowles K; Finnema SJ; Nabulsi N; Carson RE; Huang Y; Cai Z
Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1482-1496. PubMed ID: 34761284
[TBL] [Abstract][Full Text] [Related]
13. Validation, kinetic modeling, and test-retest reproducibility of [
Bertoglio D; Zajicek F; Lombaerde S; Miranda A; Stroobants S; Wang Y; Dominguez C; Munoz-Sanjuan I; Bard J; Liu L; Verhaeghe J; Staelens S
J Cereb Blood Flow Metab; 2022 Oct; 42(10):1867-1878. PubMed ID: 35570828
[TBL] [Abstract][Full Text] [Related]
14. Optimal Acquisition Time Window and Simplified Quantification of Dopamine Transporter Availability Using 18F-FE-PE2I in Healthy Controls and Parkinson Disease Patients.
Sonni I; Fazio P; Schain M; Halldin C; Svenningsson P; Farde L; Varrone A
J Nucl Med; 2016 Oct; 57(10):1529-1534. PubMed ID: 27230923
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic evaluation of [
Kramer V; Juri C; Riss PJ; Pruzzo R; Soza-Ried C; Flores J; Hurtado A; Rösch F; Chana-Cuevas P; Amaral H
Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1927-1937. PubMed ID: 31788709
[TBL] [Abstract][Full Text] [Related]
16. Quantification of dopamine transporter density with [18F]FECNT PET in healthy humans.
Nye JA; Votaw JR; Bremner JD; Davis MR; Voll RJ; Camp VM; Goodman MM
Nucl Med Biol; 2014 Mar; 41(3):217-22. PubMed ID: 24533985
[TBL] [Abstract][Full Text] [Related]
17. Quantification of 18F-JNJ-42259152, a novel phosphodiesterase 10A PET tracer: kinetic modeling and test-retest study in human brain.
Van Laere K; Ahmad RU; Hudyana H; Dubois K; Schmidt ME; Celen S; Bormans G; Koole M
J Nucl Med; 2013 Aug; 54(8):1285-93. PubMed ID: 23843566
[TBL] [Abstract][Full Text] [Related]
18. Evaluating infusion methods and simplified quantification of synaptic density
Asch RH; Naganawa M; Nabulsi N; Huan Y; Esterlis I; Carson RE
J Cereb Blood Flow Metab; 2023 Dec; 43(12):2120-2129. PubMed ID: 37669455
[TBL] [Abstract][Full Text] [Related]
19. Cortical abnormalities of synaptic vesicle protein 2A in focal cortical dysplasia type II identified in vivo with
Tang Y; Yu J; Zhou M; Li J; Long T; Li Y; Feng L; Chen D; Yang Z; Huang Y; Hu S
Eur J Nucl Med Mol Imaging; 2022 Aug; 49(10):3482-3491. PubMed ID: 34978594
[TBL] [Abstract][Full Text] [Related]
20. Effect of Shortening the Scan Duration on Quantitative Accuracy of [
Tuncel H; Visser D; Yaqub M; Timmers T; Wolters EE; Ossenkoppele R; van der Flier WM; van Berckel BNM; Boellaard R; Golla SSV
Mol Imaging Biol; 2021 Aug; 23(4):604-613. PubMed ID: 33496930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
